Cargando…

Tobacco Exposure May Enhance Inflammation in Prostate Carcinoma Patients: An Explorative Study in North Indian Population

Prostate cancer is responsible for major deaths globally after lung cancer. However, etiology of prostate cancer is still unknown. Individual risk and incidence of prostate cancer may result from the interaction of genetic susceptibility with exposure to environmental factors such as infectious agen...

Descripción completa

Detalles Bibliográficos
Autores principales: Dwivedi, Shailendra, Goel, Apul, Mandhani, Anil, Khattri, Sanjay, Pant, Kamlesh Kumar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3532779/
https://www.ncbi.nlm.nih.gov/pubmed/23293472
http://dx.doi.org/10.4103/0971-6580.103681
_version_ 1782254344829140992
author Dwivedi, Shailendra
Goel, Apul
Mandhani, Anil
Khattri, Sanjay
Pant, Kamlesh Kumar
author_facet Dwivedi, Shailendra
Goel, Apul
Mandhani, Anil
Khattri, Sanjay
Pant, Kamlesh Kumar
author_sort Dwivedi, Shailendra
collection PubMed
description Prostate cancer is responsible for major deaths globally after lung cancer. However, etiology of prostate cancer is still unknown. Individual risk and incidence of prostate cancer may result from the interaction of genetic susceptibility with exposure to environmental factors such as infectious agents, tobacco, occupational exposure, dietary carcinogens, and/or hormonal imbalances leading to injury of the prostate and to the development of chronic inflammation. About 30% of all human cancers are caused by tobacco smoking and inhaled pollutants. Inflammation is now regarded as an important hallmark of cancer. The present study has been aimed to explore the pro-inflammatory levels in prostate carcinoma patients by examining the serum levels of novel cytokine interleukin-18 (IL-18) expression in tobacco exposed population. A total of 578 (n = 284 biopsy proven prostate cancer patients, n = 294 controls with and without tobacco exposed population) were recruited. Serum IL-18 (Interleukin-18) level was done by ELISA. The IL-18 levels between cancer patients and controls within same mode tobacco exposure as tobacco smoking (overall) showed significant difference (P < 0.0001) and further we compared within stratified group, it significantly differ (P < 0.0001) in bidi and cigarette smoking than control non users. Furthermore, IL-18 levels in tobacco chewers (overall) with gutkha and khaini chewers showed significant difference (P < 0.01) than controls non users. Moreover, the IL-18 levels between cancer patients and controls with in of combined mode chewers smokers and alcohol (CSA), smokers with alcohol showed significant difference (P < 0.01) than controls. The IL-18 levels also differed significantly (P < 0.05) with smokers and chewers in higher stages of III and IV, and showed non significant with in lower stages. Tobacco exposure enhance the inflammation in prostate carcinoma patients in stratified group as it have been represented as a risk factors in various cancers, but this study provide further its role that seems to influence inflammation especially in prostate carcinoma.
format Online
Article
Text
id pubmed-3532779
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-35327792013-01-04 Tobacco Exposure May Enhance Inflammation in Prostate Carcinoma Patients: An Explorative Study in North Indian Population Dwivedi, Shailendra Goel, Apul Mandhani, Anil Khattri, Sanjay Pant, Kamlesh Kumar Toxicol Int Original Article Prostate cancer is responsible for major deaths globally after lung cancer. However, etiology of prostate cancer is still unknown. Individual risk and incidence of prostate cancer may result from the interaction of genetic susceptibility with exposure to environmental factors such as infectious agents, tobacco, occupational exposure, dietary carcinogens, and/or hormonal imbalances leading to injury of the prostate and to the development of chronic inflammation. About 30% of all human cancers are caused by tobacco smoking and inhaled pollutants. Inflammation is now regarded as an important hallmark of cancer. The present study has been aimed to explore the pro-inflammatory levels in prostate carcinoma patients by examining the serum levels of novel cytokine interleukin-18 (IL-18) expression in tobacco exposed population. A total of 578 (n = 284 biopsy proven prostate cancer patients, n = 294 controls with and without tobacco exposed population) were recruited. Serum IL-18 (Interleukin-18) level was done by ELISA. The IL-18 levels between cancer patients and controls within same mode tobacco exposure as tobacco smoking (overall) showed significant difference (P < 0.0001) and further we compared within stratified group, it significantly differ (P < 0.0001) in bidi and cigarette smoking than control non users. Furthermore, IL-18 levels in tobacco chewers (overall) with gutkha and khaini chewers showed significant difference (P < 0.01) than controls non users. Moreover, the IL-18 levels between cancer patients and controls with in of combined mode chewers smokers and alcohol (CSA), smokers with alcohol showed significant difference (P < 0.01) than controls. The IL-18 levels also differed significantly (P < 0.05) with smokers and chewers in higher stages of III and IV, and showed non significant with in lower stages. Tobacco exposure enhance the inflammation in prostate carcinoma patients in stratified group as it have been represented as a risk factors in various cancers, but this study provide further its role that seems to influence inflammation especially in prostate carcinoma. Medknow Publications & Media Pvt Ltd 2012 /pmc/articles/PMC3532779/ /pubmed/23293472 http://dx.doi.org/10.4103/0971-6580.103681 Text en Copyright: © Toxicology International http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Dwivedi, Shailendra
Goel, Apul
Mandhani, Anil
Khattri, Sanjay
Pant, Kamlesh Kumar
Tobacco Exposure May Enhance Inflammation in Prostate Carcinoma Patients: An Explorative Study in North Indian Population
title Tobacco Exposure May Enhance Inflammation in Prostate Carcinoma Patients: An Explorative Study in North Indian Population
title_full Tobacco Exposure May Enhance Inflammation in Prostate Carcinoma Patients: An Explorative Study in North Indian Population
title_fullStr Tobacco Exposure May Enhance Inflammation in Prostate Carcinoma Patients: An Explorative Study in North Indian Population
title_full_unstemmed Tobacco Exposure May Enhance Inflammation in Prostate Carcinoma Patients: An Explorative Study in North Indian Population
title_short Tobacco Exposure May Enhance Inflammation in Prostate Carcinoma Patients: An Explorative Study in North Indian Population
title_sort tobacco exposure may enhance inflammation in prostate carcinoma patients: an explorative study in north indian population
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3532779/
https://www.ncbi.nlm.nih.gov/pubmed/23293472
http://dx.doi.org/10.4103/0971-6580.103681
work_keys_str_mv AT dwivedishailendra tobaccoexposuremayenhanceinflammationinprostatecarcinomapatientsanexplorativestudyinnorthindianpopulation
AT goelapul tobaccoexposuremayenhanceinflammationinprostatecarcinomapatientsanexplorativestudyinnorthindianpopulation
AT mandhanianil tobaccoexposuremayenhanceinflammationinprostatecarcinomapatientsanexplorativestudyinnorthindianpopulation
AT khattrisanjay tobaccoexposuremayenhanceinflammationinprostatecarcinomapatientsanexplorativestudyinnorthindianpopulation
AT pantkamleshkumar tobaccoexposuremayenhanceinflammationinprostatecarcinomapatientsanexplorativestudyinnorthindianpopulation